Clincosm LogoSign in Get a demo

egfr l858r

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Plasma ctDNA
  • FFPE blocks
  • Angers, France
  • +35 more
Sep 19, 2023

Nonsquamous NSCLC, EGFR L858R, EGFR Exon 19 Deletion Trial in Worldwide (Patritumab Deruxtecan, Platinum-based chemo)

Recruiting
  • Nonsquamous Non-small Cell Lung Cancer
  • +2 more
  • Patritumab Deruxtecan
  • Platinum-based chemotherapy
  • Anchorage, Alaska
  • +182 more
Jan 17, 2023

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022